Pfizer Inc (PFE)

Healthcare | Drug Manufacturers General
Latest reporting period: 2025-03-29

Latest Quarter

2025-03-29

Revenue

$13.7B

Net Income

$3.0B

Operating Margin

32.3%

Free Cash Flow

$9.1B

Debt / Assets

58.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Pfizer Inc (PFE).
Income Statement (Quarterly) 2025-03-29 2024-12-31 2024-09-30 2024-09-29
Revenue 13,715,000,000 17,763,000,000 17,702,000,000 17,702,000,000
Cost of Revenue 2,845,000,000 5,909,000,000 5,263,000,000 6,575,000,000
Gross Profit 10,870,000,000 11,854,000,000 12,439,000,000 11,127,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 3,031,000,000 4,274,000,000 3,244,000,000 3,244,000,000
Operating Expenses 6,445,000,000 8,668,000,000 7,154,000,000 5,842,000,000
Operating Income 4,425,000,000 3,187,000,000 5,285,000,000 5,284,000,000
Interest Expense 654,000,000 739,000,000 783,000,000 783,000,000
Income Before Tax 2,785,000,000 -10,000,000 4,715,000,000 4,715,000,000
Income Tax Expense -189,000,000 -421,000,000 234,000,000 234,000,000
Net Income 2,967,000,000 410,000,000 4,465,000,000 4,465,000,000
Per Share
EPS 0.52 0.07 0.79 0.79
EPS Diluted 0.00 0.00 0.00 0.00